- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x 8DZ: (1,4-diazepane-1,4-diyl)di(propane-3,1-diyl) bis(3,4,5-trimethoxybenzoate)(Non-covalent)
8DZ.19: 32 residues within 4Å:- Chain A: L.27, W.30, N.31, M.34, T.35, T.37, N.82, M.85, T.86, A.89, M.90, L.93, N.152, G.155, Q.159, F.163, Q.181, G.185, A.188, S.189, M.192, F.269, I.273, F.276, P.277, F.303, N.307, R.314, L.407, C.408, L.411, A.415
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:M.34, A:T.35, A:F.303, A:L.411
- Hydrogen bonds: A:W.30, A:Q.159, A:N.307
- Water bridges: A:T.86, A:R.314
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wright, N.J. et al., Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat.Struct.Mol.Biol. (2019)
- Release Date
- 2019-07-03
- Peptides
- Equilibrative nucleoside transporter 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x 8DZ: (1,4-diazepane-1,4-diyl)di(propane-3,1-diyl) bis(3,4,5-trimethoxybenzoate)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wright, N.J. et al., Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat.Struct.Mol.Biol. (2019)
- Release Date
- 2019-07-03
- Peptides
- Equilibrative nucleoside transporter 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.